Glucagon-like peptide-1 receptor agonism in heart failure with improved ejection fraction; PRAISE-HFiEF
Heart failure with improved ejection fraction (HFimpEF) is an emerging phenotype defined by prior systolic dysfunction with subsequent EF recovery, yet relapse and residual risk remain substantial.1 Obesity and diabetes are prevalent drivers of ongoing risk. GLP-1 receptor agonists (GLP-1RA) improve outcomes in H...